Volume 14, Number 10—October 2008
Research
Prophylaxis after Exposure to Coxiella burnetii
Table 2
Probability of adverse events associated with postexposure prophylactic antimicrobial agents
Level of adverse event | Doxycycline* |
Trimethoprim-sulfamethoxazole† |
|||
---|---|---|---|---|---|
Best estimate | Upper bound† | Best estimate | Upper bound | ||
Moderate | 1.01% | 3.03% | 3.90% | 11% | |
Severe | 0.01% | 0.03% | 0.00123% | 0.00370%‡ | |
Death | 0.00% | 0.01% | 0.00037% | 0.00111% |
*Recommended for the general population and high-risk populations based on estimated use of 100 mg orally 2×/d for 5 d.
†Recommended for pregnant women based on 160 mg/800 mg orally 2×/d for the duration of the pregnancy.
‡Arbitrary upper-bound, 3× best estimate (see text for further details).